GRI - GRI Bio, Inc.
2.4
0 0%
Share volume: 19,212
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$2.40
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-14-2025 | 05-15-2025 | 11-14-2025 | 01-30-2026 | |
| Assets | |||||
| Total Assets | 5.739 M | 4.042 M | 4.782 M | 8.666 M | |
| Current Assets | 5.615 M | 3.930 M | 4.697 M | 8.592 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.028 M | 3.281 M | 4.055 M | 8.229 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.000 K | 3.000 K | 1.000 K | 3.000 K | |
| Other Assets | 120.000 K | 109.000 K | 84.000 K | 71.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 5.739 M | 4.042 M | 4.782 M | 8.666 M | |
| Total liabilities | 1.707 M | 2.837 M | 2.789 M | 2.658 M | |
| Total current liabilities | 1.636 M | 2.779 M | 2.759 M | 2.643 M | |
| Accounts Payable | 897.000 K | 1.361 M | 1.317 M | 1.837 M | |
| Other liabilities | 71.000 K | 58.000 K | 30.000 K | 15.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 71.000 K | 58.000 K | 30.000 K | 15.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.032 M | 1.205 M | 1.993 M | 6.008 M | |
| Common stock | 43.772 M | 43.991 M | 51.030 M | 57.704 M | |
| Retained earnings | -39.740 M | -42.786 M | -49.037 M | -51.696 M |